Viagra Patent Ruling Could Deter Appeal, Support Pfizer Position In Pending Cases
Teva Pharmaceuticals USA Inc. is considering whether to appeal a federal court decision upholding the validity of Pfizer Inc.'s Viagra (sildenafil) patent.
You may also be interested in...
After losing patent infringement suit against Merus involving antibody-producing mouse, Regeneron fights ruling that it withheld material information in prosecuting the patent.
Patent settlement will enable Teva to enter the market more than three years before Viagra’s use patent expires; Pfizer suddenly parts ways with General Counsel Amy Schulman.
Apotex has launched sildenafil for treatment of pulmonary arterial hypertension; its product is bioequivalent to Revatio, Pfizer’s sildenafil formulation for PAH, not Viagra; FDA also approved Watson, Dr. Reddy’s and Torrent sildenafil ANDAs.